Kalaris Therapeutics Inc (KLRS)

Nov 03, 2025

KLRS Sees New Analyst Rating: Citizens Initiates with Market Out - GuruFocus

Nov 03, 2025

Nov 03, 2025

Tools to assess Kalaris Therapeutics Inc.’s risk profileMarket Volume Report & Safe Swing Trade Setups - newser.com

Nov 03, 2025

Nov 03, 2025

Can trapped investors hope for a rebound in Kalaris Therapeutics Inc.Bull Run & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics appoints Matthew Gall as chief financial officer By Investing.com - Investing.com UK

Nov 03, 2025

Nov 03, 2025

What MACD and RSI say about Kalaris Therapeutics Inc.Market Growth Review & Safe Swing Trade Setups - newser.com

Nov 03, 2025

Nov 03, 2025

How Kalaris Therapeutics Inc. stock performs in rate cut cycles2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics Appoints New CFO Matthew Gall - TipRanks

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics appoints Matthew Gall as chief financial officer - Investing.com

Nov 03, 2025

Nov 03, 2025

Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer - The Manila Times

Nov 03, 2025

Nov 03, 2025

Kalaris (KLRS) names Matthew Gall CFO amid Phase 1b/2 nAMD study enrollment - Stock Titan

Nov 03, 2025

Nov 03, 2025

Analyzing Kalaris Therapeutics Inc. with risk reward ratio chartsJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025

Nov 03, 2025

What’s next for Kalaris Therapeutics Inc. stock price2025 Short Interest & Target Return Focused Stock Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Will Kalaris Therapeutics Inc. outperform the marketPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Kalaris Therapeutics Inc. rally from current levelsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

What to expect from Kalaris Therapeutics Inc. in the next 30 daysWatch List & Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025

Nov 03, 2025

Is Kalaris Therapeutics Inc. stock positioned for digital transformationQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com

Nov 03, 2025

Nov 03, 2025

Citizens initiates Kalaris stock with Market Outperform rating, $20 price target - Investing.com

Nov 03, 2025

Nov 02, 2025

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Declines By 40.5% - MarketBeat

Nov 02, 2025

Nov 02, 2025

How resilient is Kalaris Therapeutics Inc. stock in market downturnsTrade Performance Summary & Safe Swing Trade Setups - newser.com

Nov 02, 2025

Oct 31, 2025

How to use a screener to detect Kalaris Therapeutics Inc. breakoutsJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com

Oct 31, 2025

Oct 31, 2025

Kalaris Therapeutics Inc. stock outlook for YEAR2025 Performance Recap & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 05:04:53 - newser.com

Oct 31, 2025

Oct 31, 2025

Identifying reversal signals in Kalaris Therapeutics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - newser.com

Oct 31, 2025

Oct 30, 2025

Kalaris to Present at Stifel 2025 Annual Healthcare Conference - Investing News Network

Oct 30, 2025

Oct 30, 2025

Kalaris (Nasdaq: KLRS) to present at Stifel Healthcare Conference; CEO & CMO 3:20–3:50 ET - Stock Titan

Oct 30, 2025